| Dr Ludwik S Szymanski, | |
|
300 Longwood Ave, Boston, MA 02115-5724 | |
| (617) 355-6741 | |
| Not Available |
| Full Name | Dr Ludwik S Szymanski |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003984972 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ludwik S Szymanski, 53 W Boulevard Rd, Newton Centre, MA 02459-1218 Ph: (617) 969-2839 | Dr Ludwik S Szymanski, 300 Longwood Ave, Boston, MA 02115-5724 Ph: (617) 355-6741 |
News Archive
Genentech, Inc., a member of the Roche Group, and Biogen Idec today announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease. Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate.
Intellipharmaceutics International Inc., today announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for approval to market a generic of the 30 mg strength of Focalin XR® (dexmethylphenidate hydrochloride). The application for the 30 mg strength is filed as an amendment to the ANDA that Intellipharmaceutics had previously filed for the 5, 10, 15 and 20 mg strengths of the drug.
A team of UCLA researchers found that there are several parts of California where, in a high percentage of people with thyroid cancer, the disease is already at an advanced stage by the time it is diagnosed.
Cancer treatments that mobilize the body's immune system to fight the disease have generated a lot of excitement in the past few years.
Concerned members of the cancer community, including physicians, patient organizations and other care advocates, spoke out today in opposition to a proposed federal policy under consideration by the Centers for Medicare and Medicaid Services (CMS) that would lump life-saving radiation therapy in with diagnostic testing services in receiving major Medicare funding cuts.
› Verified 4 days ago
Dr. Lee Edwin Goldstein, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 670 Albany St, Boston, MA 02118 Phone: 617-414-8361 Fax: 617-414-7073 | |
Dr. Joseph Yeretsian, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 361 Newbury St Fl 5, Boston, MA 02115 Phone: 617-865-4910 Fax: 617-507-1426 | |
Dr. Michael Gulliver Erkkinen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Dr. Joseph Jeffrey Taylor, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 60 Fenwood Rd, Boston, MA 02115 Phone: 617-732-5500 | |
Sanjay Menon, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 55 Fruit St., Massachusetts General Hospital, Boston, MA 02114 Phone: 857-238-5600 | |
Lara Basovic, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 15 Parkman St Fl 8, Boston, MA 02114 Phone: 617-726-3311 Fax: 617-726-9250 | |
Ms. Ruth Farrell Mccann, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 |